The Medical Research Council Biostatistics Unit is part of the University of Cambridge, School of Clinical Medicine.
We provide a unique and stimulating environment that results in world-leading biostatistics research.
Our researchers work across four major themes
Clinical trials give the best evidence about the benefits and harms of drugs and other health interventions. This research theme aims to improve how clinical trials are run and then, once the study has completed, how the data collected are analysed and interpreted. Read more.
In the past decade, biological and medical research has changed dramatically with the ability to sequence genomes in a cost-effective way and to measure thousands of biological markers that characterise normal or pathological processes. Such knowledge has a huge potential to improve our understanding of diseases such as cancer, diabetes, cardiovascular and infectious diseases. Read more.
Health-related decision making, whether at population or individual level, needs an understanding of how diseases spread and how interventions will impact on them. This often requires us to identify and combine many sources of information so that recommendations and subsequent decisions are based on a relevant and sound evidence base. Read more.
The human and financial costs associated with medical research motivate efforts to make the best possible use of the data collected. Current medical research requires the analysis of data that can be very complex, with much of it derived from recording information for individuals at various points in time. Read more.
The MRC Biostatistics Unit (BSU) is very pleased to announce that on the 1st December 2016, the Unit transferred to…
A team of Cambridge researchers, including Dr Chris Wallace and Dr Steven Hill from the MRC Biostatistics Unit, have discovered…
In an article published in Nature Microbiology today, Dr. Paul DW Kirk from MRC Biostatistics Unit, together with Drs. Maxime…